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Abstract
Transcatheter ablation of renal autonomic nerves is a viable option for the treatment of resistent 
arterial hypertension; however, structured preclinical evaluation with standardization of analytical 
procedures remains a clear gap in this field. Here we discuss the topics relevant to the preclinical 
model for the evaluation of renal denervation (RDN) devices and report methodologies and 
criteria towards standardization of the safety and efficacy assessment, including histopathological 
evaluations of the renal artery, peri-arterial nerves, and associated peri-adventitial tissues. The 
preclinical swine renal artery model can be used effectively to assess both the safety and efficacy 
of RDN technologies. Assessment of the efficacy of RDN modalities primarily focuses on the 
determination of the depth of penetration of treatment-related injury (eg, necrosis) of the peri-
arterial tissues and its relationship (ie, location and distance) and affect on the associated renal 
nerves and the correlation thereof with proxy biomarkers including renal norepinephrine 
concentrations and nerve-specific immunohistochemical stains (eg, tyrosine hydroxylase). The 
safety evaluation of RDN technologies involves assessing for adverse effects on tissues local to 
the site of treatment (ie, on the arterial wall) as well as tissues at a distance (eg, soft tissue, veins, 
arterial branches, skeletal muscle, adrenal gland, ureters). Increasing experience will help to create 
a standardized means of examining all arterial beds subject to ablative energy and in doing so 
enable us to proceed to optimize development and assessment of these emerging technologies.
Introduction
The renal autonomic nervous system plays a major role in the development of arterial 
hypertension (1). Despite the adoption of contemporary pharmacological treatment, a 
substantial proportion of patients remain at high risk for subsequent cardio– and 
cerebrovascular events due to unexplained resistance to drug treatment (2). Renal 
sympathetic denervation has recently been introduced as a promising option for the 
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treatment of resistant hypertension. Indeed, catheter based radiofrequency (RF) renal 
denervation has demonstrated effectiveness in clinical studies (3). The increasing prevalence 
of patients suffering from resistant hypertension on a global scale (2) and the appeal of 
definitive intervention without life-long obligate adherence to repeated drug dosing has 
generated fierce demand to refine current catheter-based renal denervation procedures and 
technologies. To this effect, a variety of technological innovations such as RF and 
ultrasound catheters, catheter-based micro-infusion of neurotoxic drugs, and externally 
applied focused ultrasound have been developed, and pre-clinical studies for those devices 
are ongoing (4). The main objective of these technological endeavors pertains to the 
effective destruction of peri-arterial sympathetic nerves while preserving arterial 
morphology and renal function.
In this regard, histopathological assessment of the renal vasculature, along with biomarker 
analysis of hormones and neurotransmitters, surrounding sympathetic nerves and other 
regional soft tissue structures is critically important. However, there remains a clear lack of 
standardization with respect to the histopathological assessment of these tissues following 
denervation procedures. Most recently, the failure of the first randomized, sham-controlled 
clinical trial (SYMPLICITY HTN-3) to reach its primary efficacy endopoint at 6 months 
underscores the need to revisit existing preclinical animal models (5), since there is is no 
marker of procedural efficacy (ie, confirmation of effective and complete denervation) in 
humans. In this regard, we aim to establish standardized and reproducible methodology and 
criteria for histopathological evaluation following renal sympathetic denervation.
Animal model systems
There are a number of means of applying energy to the arterial bed and a number of animal 
models in which such energies can be applied. The early literature in this field dates back to 
the ground breaking work of Goldblatt and colleagues who in the 1930’s imposed unilateral 
or bilateral renal arterial constriction to provoke ischemia and release of renin to induce 
hypertension (6). Their work in dogs defined renal vascular hypertension, helped define the 
renin-angiotensin-aldosterone system and was followed soon thereafter by a series of 
experiments demonstrated surgical sympathectomy as possible therapeutic intervention. 
Other renal injury models emerged including complete ablation or excision of a kidney or 
infusion of nephrotoxins systemically or locally (7). Other species were considered 
including small rodents, especially the rat, and occasionally the rabbit (8). As percutaneous 
technologies have emerged, swine has become a preferred target. Although the bulk of 
studies are performed in intact animals, it will be increasingly the case that animals with 
modified renal vasculature and preceding hypertension will be considered. As these models 
emerge, careful comparison to control states must be attained. Such definition needs to 
include not only architecture at a defined period of time but the temporal and spatial kinetics 
of the dynamics and recognition of systemic and circulating effects. These models therefore 
expand dramatically the tools available to examine ablative technologies but also 
simultaneously expand the challenges to careful and precise delineate effects. Disease 
models necessarily disrupt the normal architecture and our view of the normal state is 
inadequate. Each applied neurotoxic effect is accompanied by idiosyncratic changes and 
these must be fully defined before we can proceed with understanding how therapeutic 
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interventions play a role. It will now be especially important as well to track effects over 
time – we do not know if there is recovery of neural ablation for example. Clinical studies 
seem to foretell sustained effects but there is not a definitive time when recovery is observed 
or deemed beyond approach. As disease models are used, these time-dynamic effects will 
need to be pursued further.
Porcine renovascular anatomy
Although animal models for the assessment of renal sympathetic denervation remain under 
development, the swine model is the most frequently utilized because of similarity of 
renovascular anatomy and size to humans (9). Nevertheless, descriptions of porcine 
perirenal nerve anatomy remain meager. We examined 11 normal renal arteries from 11 pigs 
to elucidate renovascular anatomy in this species. A total of 6 to 8 sections from each renal 
artery and surrounding tissues were sectioned at 4 to 5 mm intervals following indelible ink 
marking of the ventral (orange), dorsal (black), superior (blue) and inferior (green) regions 
and subjected to routine tissue processing, paraffin embedding, sectioning at 4–5 microns 
and staining with hematoxylin and eosin (H&E) and Movat pertachrome stains. Digital 
images were prepared from H&E stained sections at ×1.25 magnification. Images were 
divided into four quadrants and analyzed using image analysis software (IP Lab for Mac OS 
X, Scanalytics, Rockville, MD). Length measurements from the luminal surface of the renal 
artery to the outer nerve contour were performed in each of the four quadrants (ventral, 
dorsal, superior, and inferior locations). Representative images of distance measurements are 
shown in Supplemental Figure 1.
Mean length of renal arteries (from aorta to renal artery bifurcation following removal and 
perfusion fixation by 10% formalin) was 2.1±0.5 cm. A total of 484 nerves from 11 renal 
arteries were identified from 39 sections (mean number of nerves / section: 12.4±5.7). The 
mean number of nerves in segments proximal (10.5±6.2), middle (12.0±4.4), and distal 
(14.0±4.4) to the renal aortic ostium were not significantly different though there was a 
trend towards greater nerves in the distal versus proximal (p=0.55 for proximal vs. middle, 
p=0.06 for proximal vs. distal, p=0.34 for middle vs. distal). The mean number of nerves in 
the ventral location (4.7±2.3) was significantly greater as compared to the dorsal location 
(2.3±1.1) (P=0.02), while there were a similar number of nerves in the superior (3.0±1.8) 
and inferior arterial locations (2.1±1.2) (P=0.19). The cumulative incidence of nerves at 
distance from lumen is shown in Figure 1. These data are at some odds with Tellez et al. 
who using renal artery nerve distribution from 5 pigs reported higher nerve density in the 
proximal segments compared to that in the middle or distal segments (10) Yet, both studies 
confirmed nerve density in normal swine less than in diseased human (11) and as such if 
these spatial differences continue to be validated, they will not only influence design of 
technology but necessitate careful maintenance of specimen alignment and location before 
affects can be adequately described or compared. Preclinical safety assessment including 
study of porcine nerve anatomy is important for a standardized evaluation of innovative 
technology targeted at renal denervation therapy. However, the findings of preclinical 
studies should be interpreted with caution, as the influence of underlying atherosclerosis in 
human arteries as well as depth of the nerve distribution may be different and cannot be 
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assessed in healthy animal models. Moreover, as discussed above further examination of 
diseased animal model systems will likely soon follow.
Norepinephrine analysis
Researchers have determined that catecholamines such as norepinephrine are important 
biomarkers that aid in the evaluation of the efficacy of novel therapies in many disease states 
including neurological disorders, metabolic disease, pain, heart disease, and more 
specifically drug resistant hypertension. Down-regulation of norepinephrine in renal tissue 
has been shown to be an indicator of the efficacy of renal denervation therapy in the 
treatment of drug-resistant hypertension (12,13). The analytical challenges present in the 
quantitative analysis of norepinephrine in renal tissue are significant. Norepinephrine is 
present in extremely low endogenous levels, and is subject to extremely rapid metabolic and 
non-metabolic oxidative degradation. Renal tissue collection techniques must be optimized 
to avoid autolysis and tissues must be rapidly frozen prior to extraction. Tissue sampling 
techniques must ensure homogenous sampling as norepinephrine is non-uniformly 
distributed in the kidney. Studies designed to correlate histopathologic findings to 
norepinephrine levels must further combine rapid sampling and stabilization of kidney tissue 
to avoid norepinephrine degradation and perfusion fixation of the arterial and peri-arterial 
tissue to optimize nerve assessment.
Historical analytical methods of detection of norepinephrine have typically employed high 
pressure liquid chromatography coupled with electrochemical detection (HPLC-EC) (14). 
HPLC-EC affords high sensitivity but lacks mass specificity and is therefore subject to 
potential interferences from a large number of endogenous and exogenous compounds.
The preferred method to quantify norepinephrine in swine renal tissue in the sub-
endogenous range best utilizes high throughput tandem mass spectrometry (HPLC-MS/MS) 
(15). Mass specificity provides the ability to differentiate norepinephrine from epinephrine 
and other endogenous catecholamines. Methods which employ a stable isotope-labeled 
analysts (16), Norepinephrine-d6, as a surrogate reference standard can leverage the fact that 
the deuterium labeled norepinephrine and unlabeled norepinephrine behave uniformly 
during extraction, chromatography, and MS/MS ionization conditions. Extraction and 
homogenization of norepinephrine from pig kidney tissue must employ a solution that helps 
enhance the stability of norepinephrine. Through the use of the stable labeled compounds 
HPLC-MS/MS can be used to determine norepinephrine at greater than two orders of 
magnitude below endogenous levels. Tissue norepinephrine concentrations in the kidney of 
the treated arteries are then compared to the tissue norepinephrine concentration in the 
contralateral untreated kidney, or to a pool of control animals (Supplemental Figure 2) and 
norepinephrine data are presented as % norepinephrine reduction from control.
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Methods of fixtaion and tissue dissection are described in Supplemental 
Methods
Macroscopic TTC Staining
It is useful in the early phase of energy-based ablative device development to 
macroscopically examine the luminal surface of acutely treated renal arteries using 2,3,5-
triphenyltetrazolium chloride (TTC) staining. TTC is not a true stain but a water soluble salt 
that is enzymatically reduced by living cells to a formazan compound which imparts a 
visibly red coloration (17). TTC staining has been used for decades in research models for 
the detection and identification of tissue injury/necrosis (e.g., myocardial (18) or cerebral 
(19) infarction) as non-viable cells lack functional enzymatic processes and do not “stain” 
but remain pale, in stark contrast to the intensely red coloration of adjacent viable tissue. As 
such, the exposure of the lumen of acutely treated renal arteries to a TTC solution allows for 
the precise delineation of the “footprint” of the energy modality and allows one to make 
macroscopic measurements and correlations with device and histologic parameters.
Histopathologic and Immunohistochemical Stains
Treatment-related soft tissue damage can sometimes be visualized grossly during dissection, 
however arterial, nerve and soft tissue damages are best visualized on H&E stained sections. 
Additional stains of elastic fibers, e.g. elastica Van Gieson or Movat pentachrome or 
Mallory trichrome stains are encouraged as these may provide helpful information with 
regards to changes in arterial morphology and tissue responses. Immunohistochemical 
staining for nerve fascicles should be considered in selected sections to evaluate for changes 
of neurotransmitters or axonal degeneration. Immunostains against S-100 protein (Marker 
for Schwann and sustentacular cells), neurofilament protein (Marker for neurons and 
ganglion cells), and glial fibrillary acidic protein (GFAP: Marker for glial cells) are used for 
the recognition of nerve fascicles (20), whereas stains targeted at tyrosine hydroxylase (TH; 
which converts tyrosine to DOPA) are used for the presence or absence of norepinephrine 
synthesis (21). Although DOPA decarboxylase (which converts DOPA to dopamine) is 
another catecholamine-synthesizing enzyme, immunostaining against DOPA decarboxylase 
is rarely used in the area of renal denervation because DOPA decarboxylase positive fibers 
are more sparsely distributed than TH positive fibers in perivascular nerves in the kidney 
(22). The combination of at least one axonal marker (S-100 protein, neurofilament protein, 
or GFAP) and a functional marker (TH) may provide meaningful insights into the functional 
relevance of ablative treatment against resistent hypertension.
Peri-arterial nerves around kidney are comprised of efferent (sympathetic) nerve fibers and 
afferent (sensory) nerve fibers, and both types of nerves may affect renal sympathetic nerve 
activity (RSNA) (23). To identify renal afferent nerves, immunostains against calcitonin 
gene-related peptide (CGRP) and Substance P, which serve as neurotransmitters in sensory 
nerves (24), have been reported in the literature. However, since immunostaining for CGRP 
using color-producing reagents has been reported to result in low intensity, the more reliably 
strong intensity of TH is most offen adopted for staining of efferent sympathetic nerve fibers 
in the immunohistochemical assessment of successful ablation of peri-arterial sympathetic 
nerves (10). Most importantly, the intensity of color reaction has been shown to be 
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correlated with presence of viable efferent sympathetic nerve fibers using TH staining (21), 
an association not found with other immunostain procedures such as CGRP or substance P.
Evaluation
Histologic assessment for nerve fascicles
Treatment related changes to peri-arterial nerves can be assessed using a semi-quantitative 
ordinal grading system that allows for the assessment of the type of change (ie, 
degeneration, necrosis, chronic, etc) and its magnitude (eg, minimal, mild, moderate, 
severe). Figure 2 provides images of a representative grading scheme that refers to effects on 
both peri- and endoneuronal tissue. The type and magnitude of changes in peri-arterial 
nerves can represent damages incurred directly with the treatment in the plane of section (ie, 
nerves that lie directly in the path of treatment) or represent changes associated with injury 
to the nerve along its length outside the plane of section (ie, upstream or downstream 
injury). Treatment may affect the perineuronal and/or endoneuronal portions of the renal 
nerves and present as degenerative, necrotic, or chronic changes. Degenerative changes 
associated with peri- or endoneuronal injury may include vacuolization and the formation of 
digestion chambers associated with injury, reversible or irreversible, to the axonal processes 
of the treated nerve. Necrotic changes may range from pyknosis/karyorrhexis of individual 
neural nuclei to coagulative necrosis or frank coagulation of the nerve bundle. After 
resolution of the acute phase of treatment, affected nerves may exhibit a variety of chronic 
changes including periand endoneural fibrosis, axonal atrophy or loss. With minimal injury 
(ie, Grade 1), the nerve would be considered largely intact, and likely functional, but exhibit 
subtle signs of damage which may include trivial perineuronal inflammation or hemorrhage 
and limited endoneuronal damage (perineuronal proteoglycan deposition, fibroplasia with 
little to no vacuolization, pyknosis or increase in cellularity). With mild injury (ie, Grade 2), 
changes are more conspicuous and/or involving more of the nerve bundle and may include 
increased cellularity, perineuronal inflammation, fibrosis and/or endoneuronal changes (eg, 
vacuolization, pyknotic nuclei, or digestion chambers). Nerves with moderate injury (ie, 
Grade 3) would be interpreted to exhibit more notable changes which may include 
perineuronal inflammation, fibrosis as well as endoneuronal damage (frequent pyknotic 
nuclei, digestion chambers, vacuolization, or swelling of endoneuronal tissue). Severe injury 
(ie, Grade 4) changes are typically overwhelming and may consist of marked perineuronal 
inflammation and/or fibrosis, and endoneurium damage including effacement of nerve 
architecture, necrosis, and axonal retraction. Since minimal or mild injury (ie, ≤ Grade 2) 
can be seen even in untreated animals, moderate or severe injury (ie, ≥ Grade 3) should be 
considered to be a definite injury caused by thermal damage or toxins and generally 
correlates with decreases in renal norepinephrine levels.
Regardless of scoring methodology, the location of all observed nerves should be denoted 
relative to the area of the treatment (i.e., within or outside the “zone of treatment”) for the 
purposes of better understanding the treatment efficacy on the total population of nerves 
available for treatment.
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Immunostaining of peri-vascular nerves and scoring criteria
The intensity and distribution of immunostaining can be assessed using a semi-quantitative 
scoring system (eg, 0= no reaction, 1= patchy/very weak reaction, 2= weak to moderate 
reaction, 3=strong reaction). Representative images of immunostaining are shown in Figure 
3. Typically, a weak reaction (ie, ≤ Grade 2), or absence of TH, represents a strong treatment 
effect as the absence of staining is an indirect sign of functional nerve degeneration and can 
be correlated with the renal norepinephrine levels. With respect to the functional assessment 
of nerve viability using immunostaining, the choice of time-point is crucial as 
immunohistochemical analysis represents a snapshot assessment in the time course of axonal 
degeneration following renal denervation procedures. If the nerves being examined are less 
than 7 days of denervation, immunostaining is usually positive despite extensive necrosis, 
therefore it is not recommended that immunostaining be performed prior to 7 days following 
denervation procedure.
Histologic assessment of renovascular morphology
Renovascular damage includes endothelial cell loss, thrombus formation and medial 
damage, which can be assessed along the depth and circumference of the artery. These 
changes can be assessed using a semi-quantitative ordinal grading system (eg, 0=none, 
1=minimal, 2=mild, 3=moderate, and 4=severe). Figure 4 provides representative images of 
a grading scheme that refers to both endothelial cell loss and medial wall damage. 
Endothelial loss should be evaluated by the percentage of circumferential endothelial cell 
loss (Figure 4). Endothelial cell loss is typically observed acutely after treatment and is 
rarely observed at 28-days. A common characteristic of thermal media injury is smooth 
muscle cell (SMC) loss/necrosis with proteoglycan and/or fibrous tissue replacement. The 
depth of media damage is evaluated by the percentage of smooth muscle cell loss in relation 
to media thickness (Figure 4). When evaluating the depth of medial damage, the presence of 
media thinning should be reported. Media thinning is defined as thickness of the media at 
the site of damage (mm)/unaffected media thickness (mm) with < 0.5 representing severe 
smooth muscle cell loss/necrosis within the media. In addition, the cross-sectional 
dimension of medial damage can be assessed as circumferential loss/necrosis of SMCs. 
When evaluating media damage, it is recommended to use the Movat pentachrome stain as 
proteoglycan deposition can be easily appreciated.
Histologic assessment for peri-arterial tissues and organs
Peri-arterial tissues such as fat, collagen, renal veins, arterioles, ureters, adrenal glands, 
skeletal muscle, viscera, and the kidney should all be systematically evaluated for signs of 
injury. Again, a semi-quantitative ordinal grading system (eg., 0=none, 1=minimal, 2=mild, 
3=moderate, and 4=severe) can be utilized to score observed changes. It is important to 
mention that the risk of thermal renal vein injury and thrombosis is far less than that of 
thermal arterial injury. Also, most venous injuries initiate at the abluminal surface, whereas 
most of arterial injuries begins at the luminal surface, of course depending upon the mode of 
denervation used. However, as the veins are thin it is important to appropriately assess the 
venous injury and/or thrombosis. Arteriolar damage usually correlates with the overall nerve 
damage. Typical severe (grade 4) injury of arterioles is fibrinoid necrosis, which is most 
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often observed acutely but often persists up to 28-days. A representative scoring criteria for 
arterioles damages is shown in Supplemental Figure 3. Injury to the ureters is evaluated by 
the extent of edema and necrosis (submucosal, muscular, and periureteral surrounding 
tissue) as well as mucosal ulceration. However, ureter injury is not frequent, because the 
remote anatomical position of the ureter relative to the ablation site precludes it from direct 
thermal injury. As a direct sign of thermal injury on collagen/adipose tissue, the presence of 
denatured collagen should be assessed, which can easily be detected by elastica stains. 
Similarly periadventitial fat may undergo necrosis with saponification and surrounding acute 
inflammation followed by chronic inflammation (25,26). This usually appears as shadowy 
outline of adipose cells with saponification. Representative scoring criteria for fat damages 
are shown in Supplemental Figure 4.
Not only are direct renal and soft tissue important but attention should be also directed 
towards lymph node damage, skeletal muscle and adjoining viscera (e.g., the cecum and 
adrenal glands). Therefore these structures should be routinely assessed by the individual 
necropsy prosector and submitted for histologic assessment for the extent and type of 
damage if present.
Advantage of the combination of various stains
The combination of an elastica stain with a standard H&E stain will more reliably allow the 
appropriate assessment of nerve injury, arterial wall injury, and soft tissue injury 
(Supplemental Figure 5) as the information of both staining protocols is cumulative. For 
example, proteoglycan replacement (green tissue) within the arterial media can easily be 
recognized by a Movat pentachrome stain. Denatured collagen is clearly distinguished as 
black tissue by Movat pentachrome stain whereas H&E gives a blue tinge of staining and 
may be difficult to identify. Also, perineural fibrosis can easily be recognized by Movat 
pentachrome stain. Therefore, we recommend using this stain as well as H&E stain routinely 
for the evaluation of arterial, soft tissue, and nerve injuries.
Quadrant analysis and deepest soft tissue damage
To capture the entire spectrum of thermal and/or toxic tissue damage along the vascular 
circumference a cross-sectional quadrant analysis is recommended as shown in 
Supplemental Figure 6 where one quadrant refers to <25% circumferential area, 2 quadrants 
26–50% circumferential area, 3 quadrants 51–75% circumferential area, and 4 quadrants 
refer to >75% circumferential area. Obtaining the number of quadrants with injured nerve 
fascicles relative to quadrants with the presence of nerve fascicles enables the capturing of 
differences in circumferential thermal injury among different devices. The distance from 
renal arterial lumen to deepest tissue damage (nerves, vein, arterioles, or other soft tissues) 
determines the effective depth of thermal and/or toxic injury among different devices. Figure 
5 shows representative images of distance measurements. Combining the information 
retrieved from cross-sectional quadrant analysis and penetration of the depth of thermal 
injury provides unique information regarding the number of quadrants affected and the 
adequacy of the denervated area in relation to circumferential discontinuity of innervation of 
the kidney.
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Summary
Summary of methodological standard for the preclinical evaluation of RDN is shown in 
Table 1. The purpose of this document is to guide and standardize the preclinical 
histopathological assessment with regards to renal sympathetic denervation procedures. 
Standardization of histopathological assessment remains an unmet need in this field, which 
may ultimately facilitate understanding of underlying mechanisms after renal denervation 
and further to help assess which device is the more appropriate and what advantages each 
device may offer from the currently available technologies. As research in this area evolves, 
updates will be mandatory to warrant appropriate adoption into clinical practice.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Abbreviations
RDN renal denervation
RF radiofrequency
HPLC-EC high pressure liquid chromatography coupled with electrochemical 
detection
HPLC-MS/MS high throughput tandem mass spectrometry
TTC staining 2,3,5-triphenyltetrazolium chloride (TTC) staining
GFAP glial fibrillary acidic protein
TH tyrosine hydroxylase
CGRP calcitonin gene-related peptide
RSNA renal sympathetic nerve activity
SMC smooth muscle cell
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Figure 1. Cumulative incidence of normal perirenal nerve distances from renal arterial lumen
The cumulative incidence of nerve distance from lumen is calculated from 484 nerves. The 
50th percentile of the distance from the arterial lumen to nerve was 2.1mm, whereas 75th 
percentile in that was 4.4 mm.
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Figure 2. Semi-quantitative grading scheme for nerve changes
Upper panel shows representative images of nerves by increasing grade of injury. Middle 
panels shows high power images of injured nerves (red boxed area in upper panels) in each 
grade. Lower panels shows representative images of vacuolization, pyknotic nuclei, 
digestion chambers, and perineurial fibrosis. All image panels are stained with H&E stain.
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Figure 3. Semi-quantitative scoring criteria for immunostain against tyrosine hydroxylase
Upper panels are representative images of injured nerves stained by anti-tyrosine 
hydroxylase (TH) enzyme. Lower panels are corresponding images of injured nerves with 
H&E and Movat pentachrome stains.
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Figure 4. Semi-quantitative grading scheme for renal artery damage
Upper panels represent depth of medial wall injury by the grade of damage, whereas lower 
panels represent circumferential grade of damage of the medial wall. Note, media thinning 
can only occur with grade 4 depth of injury and should be distinguished. All images are 
stained with Movat pentachrome.
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Figure 5. Representative images of distance from arterial lumen to various types of injury
A: Low-power image of a treated renal artery and surrounding perirenal area. B: High-
power images of injured arterioles (red boxed area in A). The distance from lumen to injured 
arterioles was 4.4 mm. C: High-power image of nerve injury (yellow boxed area in A). The 
distance from lumen to injured nerves was 2.1 mm. D: High-power image of injured nerves 
(blue boxed area in A). The distance from lumen to injured nerve was 4.1 mm. E: High-
power image of soft tissue injury (green boxed area in A). The distance from lumen to 
injured tissue was 3.2 mm.
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Table 1
Summary of methodological standard for the Preclinical Evaluation of Renal Sympathetic Denervation.
Category Methods Purpose
Biomarker Kidney norepinephrine levels (HPLC-MS/MS) Evaluation of the extent of renal sympathetic 
denervation
Macroscopic evaluation TTC staining of renal artery To assess the extent of arterial wall injury
Standard Light Microscopy and 
morphometry
Semi-quantitative scoring of pathologic changes 
(grade 0 to grade 4): Nerve, renal artery, vein, 
arterioles, fat and collagen.
To determine the extent of nerve injury, 
arterial and surrounding soft tissue injury
Quadrant analysis (0 to 4 quadrants) for nerve injury 
and soft tissue injury Evaluation of circumferential extent of injury
Depth of tissue injury (mm) Evaluation of therapeutic penetration
Immunohistochemistry Semi-quantitative scoring of intensity of 
immunostaining (score 0 to score 3) by anti-tyrosine 
hydroxylase
Evaluation of the ability of the nerves to 
generate nor-epinephrine (functional nerve 
injury)
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